FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline <i>BRCA</i>-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of ChemotherapyGeoffrey Kim, Richard Pazdur, Shenghui Tang et al.|Clinical Cancer Research|2015Cited by 526
Human papillomavirus type 16 E7 oncoprotein-induced upregulation of lysine-specific demethylase 5A promotes cervical cancer progression by regulating the microRNA-424–5p/suppressor of zeste 12 pathwayJia Liu, Yunsheng Xu, Hongqin Zhao et al.|Experimental Cell Research|2020Cited by 16